On Sept. 6, 2023, Moderna announced that clinical trial data from its research assay confirmed its updated COVID-19…
On Aug. 24, 2023, researchers at City of Hope announced were awarded $32.3 million from the California Institute…
On Aug. 22, 2023, the U.S. Department of Health and Human Services (HHS) announced it had awarded more…
On Jul. 31, 2023, the U.S. Department of Health and Human Services announced the formation of the Office…
On Jul. 28, 2023, in a first-of-its-kind clinical trial, bioelectronic medicine researchers, engineers and surgeons at Northwell Healthï¾’s…
On Jul. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $50.1 million to fund clinical-stage research…
On May 2, 2023, the U.S. FDA announced that it was taking additional steps to support the use…
On Apr. 11, 2023, a National Institutes of Health (NIH) clinical trial was stopped early because a daily…
On Jan. 18, 2023, the National Institutes of Health (NIH) announced that an investigational HIV vaccine regimen tested…
On Jan. 17, 2023, Moderna announced positive topline data from its ConquerRSV Phase 3 pivotal efficacy trial of…
On Jan. 10, 2023, the U.S. National Institutes of Health (NIH) reported that antiviral treatments can help reduce…
On Jan. 5, 2023, BioNTech announced that the Company had signed a Memorandum of Understanding with the Government…
On Dec. 8, 2022, the Department of Veterans Affairs embarked on a study to determine the most effective…
On Dec. 5, 2022, the Fred Hutchinson Cancer Center announced that according to a new meta-analysis women were…
On Dec. 2, 2022, in a multi-center collaboration led by Scripps Research, scientists announced they have achieved promising…
On Nov. 14, 2022, Moderna announced that both of Moderna’s bivalent Omicron-targeting booster candidates (mRNA-1273.214 and mRNA-1273.222) trigger…
On Nov. 7, 2022, the NHS Blood and Transplant (NHSBT) reported that red blood cells grown in a…
On Nov. 4, 2022, Pfizer and BioNTech announced updated data from a Phase 2/3 clinical trial demonstrating a…
On Nov. 1, 2022, Pfizer announced positive top-line data from the Phase 3 clinical trial (NCT04424316) MATISSE (MATernal…
On Oct. 31, 2022, the National Institutes of Health announced that a clinical trial had found that one…
On Oct. 27, 2022, Inovio Pharma announced that it has discontinued its internally funded efforts to develop INO-4800…
On Oct. 19, 2022, Moderna announced new clinical data on its bivalent Omicron-containing booster, mRNA-1273.214. Ninety days after…
On Oct. 13, 2022, Novavax announced positive results from the Phase 1/2 clinical trial of its COVID-19-Influenza Combination…
On Oct. 13, 2022, Pfizer and BioNTech announced early data from a Phase 2/3 clinical trial (NCT05472038) evaluating…
On Oct. 11, 2022, researchers from the University of Oxford have reported new findings from a Phase 1…
On Sept. 8, 2022, a clinical trial evaluating alternative strategies for administering the JYNNEOS mpox vaccine to increase…
On Sept. 7, 2022, the U.S. Food and Drug Administration (FDA) announced it had approved Revance Therapeutics’ DAXXIFY…
On Aug. 23, 2022, Moderna announced that it has completed its submission to the U.S. Food and Drug…
On Aug. 4, 2022, Novavax announced the initiation of its Phase 2b/3 Hummingbird global clinical trial. The trial…
On Jul. 19, 2022, the NIH announced that although COVID-19 booster vaccinations in adults elicit high levels of…